The purpose of this study is the use of buprenorphine/naloxone in treatment of opioid
The objective of this study is to determine the safety and efficacy of a
buprenorphine/naloxone combination tablet for opiate dependence treatment.
DSM-IV diagnosis of current opiate dependence males and non-pregnant, non-nursing female
18-59 yrs of age
Any significant medical condition AST or ALT levels greater than 3x's the upper limit of
normal level Current Axis I diagnosis other than opiate, caffeine or nicotine dependence